Gary Goldenberg - Net Worth and Insider Trading

Gary Goldenberg Net Worth

The estimated net worth of Gary Goldenberg is at least $120,654 dollars as of 2024-10-09. Gary Goldenberg is the Chief Medical Officer of Verrica Pharmaceuticals Inc and owns about 94,261 shares of Verrica Pharmaceuticals Inc (VRCA) stock worth over $120,654. Details can be seen in Gary Goldenberg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gary Goldenberg has not made any transactions after 2024-08-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gary Goldenberg

To

Gary Goldenberg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gary Goldenberg owns 1 companies in total, including Verrica Pharmaceuticals Inc (VRCA) .

Click here to see the complete history of Gary Goldenberg’s form 4 insider trades.

Insider Ownership Summary of Gary Goldenberg

Ticker Comapny Transaction Date Type of Owner
VRCA Verrica Pharmaceuticals Inc 2024-08-27 director

Gary Goldenberg Latest Holdings Summary

Gary Goldenberg currently owns a total of 1 stock. Gary Goldenberg owns 94,261 shares of Verrica Pharmaceuticals Inc (VRCA) as of August 27, 2024, with a value of $120,654.

Latest Holdings of Gary Goldenberg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VRCA Verrica Pharmaceuticals Inc 2024-08-27 94,261 1.28 120,654

Holding Weightings of Gary Goldenberg


Gary Goldenberg Form 4 Trading Tracker

According to the SEC Form 4 filings, Gary Goldenberg has made a total of 4 transactions in Verrica Pharmaceuticals Inc (VRCA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Verrica Pharmaceuticals Inc is the sale of 13,489 shares on August 27, 2024, which brought Gary Goldenberg around $35,206.

Insider Trading History of Gary Goldenberg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gary Goldenberg Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gary Goldenberg Ownership Network

Ownership Network List of Gary Goldenberg

No Data

Ownership Network Relation of Gary Goldenberg

Insider Network Chart

Gary Goldenberg Owned Company Details

What does Verrica Pharmaceuticals Inc do?

Who are the key executives at Verrica Pharmaceuticals Inc?

Gary Goldenberg is the director of Verrica Pharmaceuticals Inc. Other key executives at Verrica Pharmaceuticals Inc include director & President and CEO Ted White , Chief Commercial Officer Joe Bonaccorso , and General Counsel Christopher G. Hayes .

Verrica Pharmaceuticals Inc (VRCA) Insider Trades Summary

Over the past 18 months, Gary Goldenberg made 4 insider transaction in Verrica Pharmaceuticals Inc (VRCA) with a net sale of 69,548. Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net sale of 150,999 shares made by Ted White , a net sale of 130,386 shares made by Joe Bonaccorso , and a net sale of 124,941 shares made by Christopher G. Hayes .

In summary, during the past 3 months, insiders sold 245,069 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 0 shares, with a net sale of 245,069 shares. During the past 18 months, 533,677 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 2,260,199 shares were bought by its insiders, resulting in a net purchase of 1,726,522 shares.

Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Verrica Pharmaceuticals Inc Insider Transactions

No Available Data

Gary Goldenberg Mailing Address

Above is the net worth, insider trading, and ownership report for Gary Goldenberg. You might contact Gary Goldenberg via mailing address: C/o Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester Pa 19380.

Discussions on Gary Goldenberg

No discussions yet.